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Background: Adiponectin, has an antioxidant role in experimental studies, but its role in the regulation of vascular function in patients with 
atherosclerosis is unknown. We examined the impact of circulating adiponectin on vascular superoxide (O2-) and nitric oxide (NO) bioavailability in 
atherosclerosis.
Methods: In this study, 320 patients undergoing coronary bypass operation were recruited. Endothelial function was estimated in the brachial 
artery by flow mediated dilation (FMD) and in SV segments ex vivo, by determining vasorelaxations in response to acetylcholine (ACh). Plasma 
adiponectin was measured preoperatively. Vascular O2- was measured by lucigenin chamiliminescence in saphenous veins (SV) and mammary 
arteries (IMA) +/- LNAME (an endothelial nitric oxide synthase (eNOS) inhibitor).
Results: Circulating adiponectin was positively associated with FMD (r=0.310, p=0.032) and vasorelaxations of SV segments in response to ACh 
(Fig.A). Adiponectin was negatively associated with vascular O2- in both SV and IMA (Fig. B), while low adiponectin was associated with increased 
LNAME inhibitable O2-, suggesting more eNOS uncoupling (Fig. C).
Conclusions: This is the first study demonstrating that adiponectin has a direct impact on NO bioavailability in human vessels, by improving eNOS 
coupling and suppressing vascular O2- generation in patients with atherosclerosis. These novel findings suggest that adiponectin may be directly 
involved in the regulation of vascular redox state in humans.
